BD Alaris Systems Manager/CQI Reporter cleartext transmission

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
3.0$0-$5k0.00

Summaryinfo

A vulnerability described as problematic has been identified in BD Alaris. The affected element is an unknown function of the component Systems Manager/CQI Reporter. Executing a manipulation can lead to cleartext transmission. The identification of this vulnerability is CVE-2023-30565. The attack needs to be done within the local network. There is no exploit available.

Detailsinfo

A vulnerability classified as problematic was found in BD Alaris (Medical Device Software) (unknown version). This vulnerability affects an unknown code block of the component Systems Manager/CQI Reporter. The manipulation with an unknown input leads to a cleartext transmission vulnerability. The CWE definition for the vulnerability is CWE-319. The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors. As an impact it is known to affect confidentiality. CVE summarizes:

An insecure connection between Systems Manager and CQI Reporter application could expose infusion data to an attacker.

The weakness was shared 07/13/2023. The advisory is shared for download at bd.com. This vulnerability was named CVE-2023-30565 since 04/12/2023. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1040.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Productinfo

Type

Vendor

Name

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 3.0
VulDB Meta Temp Score: 3.0

VulDB Base Score: 2.6
VulDB Temp Score: 2.6
VulDB Vector: 🔍
VulDB Reliability: 🔍

CNA Base Score: 3.5
CNA Vector (Becton, Dickinson and Company (BD)): 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Cleartext transmission
CWE: CWE-319 / CWE-310
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

04/12/2023 🔍
07/13/2023 +92 days 🔍
07/13/2023 +0 days 🔍
07/13/2023 +0 days 🔍

Sourcesinfo

Advisory: bd.com
Status: Confirmed

CVE: CVE-2023-30565 (🔍)
GCVE (CVE): GCVE-0-2023-30565
GCVE (VulDB): GCVE-100-234064

Entryinfo

Created: 07/13/2023 22:48
Changes: 07/13/2023 22:48 (48)
Complete: 🔍
Cache ID: 216::103

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!